Document used for a speech at Doctors20 (Paris June 5-7, 2013), featuring MediQuality and on-line physisician communities. MedIQuality is among the most active on-line physician communities in Europe

1. Paris June 6-7, 2013
June 6-7, 2013

2. Paris - June 6-7, 2013
About MediQuality and others
« On-Line Physician Communities »
The Value for Physicians and for
Pharmaceutical Companies
Pierre De Nayer,
@pdenayer,
denap@citobi.com

3. >3 million doctors are members
of online professional networks
• Alliance of 20 physician communities
• Over 2 million doctors are part of the
Networks in Health communities
• 600,000 doctors in Europe 5

4. A Truly Global Reach

5. Paris June 6-7, 2013
The 8 minutes agenda
• What are physicians doing on « on-line
physician communities »?
• Is your audience ready?
• Zoom on MediQuality.

6. Paris June 6-7, 2013
What are
physicians doing?

7. Paris June 6-7, 2013
What are physician
doing on physician
communities?
• Search info
• E-cme
• Congress highlights
• Discuss cases
• Discuss other topics
• …Secured
Environment!

8. Paris June 6-7, 2013
Is your audience
Ready?

9. Paris June 6-7, 2013
« No dancing floor… or
nobody dancing »
(Netherlands, France)

10. Paris - June 6-7, 2013
« Nearly all physicians
currently at the bar…and
some physicians dancing »
(Belgium, France,…)

11. Paris June 6-7, 2013
« A lot of physicians
dancing. You can feel the
heat… » (United States,
Germany)

12. Paris June 6-7, 2013
« Will we reach the
« foam party » stage? »
(DNUK?)

13. Paris June 6-7, 2013
Zoom on
MediQuality

14. Paris June 6-7, 2013
MediQuality in Figures
• 37 000 Members! (Belgium)
– 14500 GP’s
– 16500 SP’s
– 5000 pharmacists
– others
• Hence >85% reach
• 3200 Unique Visitors a day/
22 000 UV a month
• >700 000 OTS a month!!
• Number of discussionx x3 in 2
Years

15. Paris June 6-7, 2013

16. Paris June 6-7, 2013

17. Paris June 6-7, 2013

18. Paris June 6-7, 2013
Multiple tools & sources of content
for tailored engagement plans
p. 18
•Coverage of congresses (incl videos) with vairous communications over a
short periodCongresses
•Descriptions, auto-tests, potentially accreditedeCME modules
•Articles suggestions & summaryLitterature
•Patient cases with questionnaire with immediate resultsPatient cases
•Experience & opinion polls
•Tailored to theme, situation and objectivesSurveys / Polls
•Discussion Forum / Groups
•Interactive quizzes, video footageInteractive

19. Paris June 6-7, 2013
« Topic Center » learnings
• > 3200 members in 6 months
• Physisians re-visiting (2,5 visits per UV)
• Average time spent: 3 mins
• High impact on credibility, image, etc…
• But animation plan needed for less « sexy »
topics (Arthritis, Nocturnal Enuresis?)

20. Paris June 6-7, 2013
What did we learn from others?
« FaceBook » like
approach tested
succesfully !

21. Paris June 6-7, 2013
The IMPACT of discussion…
A « key drug » case (1/2)
20/10/2011 - 22h51 - A propos de ce risque "triplé voire quadruplé": je me suis procuré l'article en question grâce à la sympathique
collaboration de la 1e auteur, le Dr Charlotte van Noord. Voici les chiffres:
- étude uniquement épidémiologique
- cohorte de 1 million de personnes, suivie pendant 10 ans
- population retenue: 1366 cas de mort subite "cardiaque" (probable)
- dans cette population: seulement 10 cas (!) associés à une prise de Motilium ou domperidone au moment de l'arrêt cardiaque... (aucun
lien de causalité établi, seulement une relation temporelle)
- population contrôle: 14.114 sujets, dont 26 sous Motilium...
- et aussi: moyenne d'âge dans le groupe étudié 72 ans, mais dans le groupe contrôle 66 ans; ceci est certainement significatif vu les
grands nombres, mais ce n'est pas mentionné dans l'article...
Alors ? la différence entre ces deux proportions est STATISTIQUEMENT significative vu les grands nombres, mais pas CLINIQUEMENT
significative !
Encore une tempête dans une flaque d'eau...
Dr X. Van der Brempt, pneumo-allergologue
POSITIVE reactions from
physicians, supporting the drug.

22. Paris June 6-7, 2013
The IMPACT of discussion…
A « key drug » case (2/2)
12/10/2011 Motilium : la réaction du
CBIP
4524
11/10/2011 "Le Motilium provoque des
arrêts cardiaques inopinés"
(selon le pharmacologue
Luc Hondeghem dans
Knack)
2317
12/10/2011 Motilium: "Aucun cas de
décès lors des dix dernières
années" (Janssen
Pharmaceutica)
1563
• 11/10: first record of
readings broken
• 12/10: record record
« exploded »
• 12/10-25/10: 20 positive
posts by physicians, read
by more than 5000
readers!

23. Paris June 6-7, 2013
• Be relevant Online physician communities will work if they help
physicians…
• There are many type of physician communities. They will now
learn from each other...
• Pharmaco’s will find unique opportunities to engage with HCP on
OL physician communities
• When evaluating the power of a physician community, don’t
consider the number of interactions. Consider the number of
people that VIEW a specific discussion…
• Are OL Physician Communities the place where pharma &
physician interests will converge? (A question to the audience…)
Some concluding remarks